Anticoagulation and Subclinical Valve Thrombosis After TAVR
- PMID: 36057537
- DOI: 10.1016/j.jcin.2022.08.003
Anticoagulation and Subclinical Valve Thrombosis After TAVR
Keywords: HALT; TAVR; antithrombotic therapy; hypoattenuating leaflet thickening; thrombosis; transcatheter aortic valve replacement.
Conflict of interest statement
Funding Support and Author Disclosures Dr Dangas has received institutional research grants from Daiichi Sankyo. Dr Nicolas has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy.JACC Cardiovasc Interv. 2022 Sep 26;15(18):1794-1804. doi: 10.1016/j.jcin.2022.07.014. Epub 2022 Aug 31. JACC Cardiovasc Interv. 2022. PMID: 36137682 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical